These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 580051)

  • 21. Serum-digoxin concentrations with a new digoxin derivative, beta-methyl-digoxin.
    Härtel G; Manninen V; Melin J; Apajalahti A
    Ann Clin Res; 1973 Apr; 5(2):87-90. PubMed ID: 4748756
    [No Abstract]   [Full Text] [Related]  

  • 22. The pharmacokinetics of digoxin in patients with manifest hyperthyroidism and after normalization of thyroid function.
    Bonelli J; Haydl H; Hruby K; Kaik G
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):302-6. PubMed ID: 669876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bioavailability of Dilanacin and Dilanacin new].
    Sorger D; Gruber G
    Z Gesamte Inn Med; 1982 Dec; 37(24):849-53. PubMed ID: 7170822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enteral absoprtion of ascorbic acid in man after application of a micro-encapsulated retard preparation (author's transl)].
    Brenner G
    Med Klin; 1975 Jul; 70(28-29):1219-22. PubMed ID: 1177790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Influence of furosemide on beta-methyl-digoxin excretion in the urine (author's transl)].
    Baczýnski R; Kokot F
    Dtsch Med Wochenschr; 1978 Apr; 103(15):662-4. PubMed ID: 639708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absolute bioavailability of digoxin tablets.
    Beveridge T; Nüesch E; Ohnhaus EE
    Arzneimittelforschung; 1978; 28(4):701-3. PubMed ID: 581950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Varying renal elimination of digoxin and beta-methyl-digoxin].
    Risler T; Grabensee B; Jesdinsky HJ; Grosse-Brockhoff F
    Verh Dtsch Ges Kreislaufforsch; 1976; 42():370-2. PubMed ID: 1007602
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of digoxin absorption but not of digitoxin during cytostatic drug therapy.
    Kuhlmann J
    Arzneimittelforschung; 1982; 32(6):698-704. PubMed ID: 6889430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and metabolism of alpha-acetyldigoxin in man.
    Bodem G; Wirth K; Gernand E; Dengler HJ
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):102-16. PubMed ID: 4846188
    [No Abstract]   [Full Text] [Related]  

  • 31. [Postprandial delay of drug absorption in a gitoformate model].
    Kubin S; Woodcock BG; Menke G; Rietbrock N
    Arzneimittelforschung; 1987 Dec; 37(12):1376-8. PubMed ID: 3449065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein.
    Westphal K; Weinbrenner A; Giessmann T; Stuhr M; Franke G; Zschiesche M; Oertel R; Terhaag B; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2000 Jul; 68(1):6-12. PubMed ID: 10945310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Determination of the relative enteral activity of beta-methyl-digoxin in patients with heart failure (author's transl)].
    Ghabussi P; Krämer KD; Hochrein H
    Med Klin; 1974 May; 69(18):802-5. PubMed ID: 4837409
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on the interactions between digitalis glycosides, antibiotics and diuretics with the aid of radioimmunoassay].
    Chlewicka I
    Kardiol Pol; 1979; 22(6):611-21. PubMed ID: 529664
    [No Abstract]   [Full Text] [Related]  

  • 35. [Absorption and urinary excretion of digoxin in the presence of hyoscine butyl bromide and sulpiride in healthy subjects].
    Jiménez Alonso J; Castillo-Ferrando JR; Bolaños J; Jaimez L; Pérez Jiménez F
    Rev Esp Cardiol; 1983; 36(2):121-3. PubMed ID: 6622791
    [No Abstract]   [Full Text] [Related]  

  • 36. The development and application of a radioimmunoassay for dihydrodigoxin, a digoxin metabolite.
    Butler VP; Tse-Eng D; Lindenbraum J; Kalman SM; Preibisz JJ; Rund DG; Wissel PS
    J Pharmacol Exp Ther; 1982 Apr; 221(1):123-31. PubMed ID: 7062278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability of digoxin from tablets. II. Radioimmunoassay and disposition pharmacokinetics of digoxin after intravenous administration.
    Nyberg L; Andersson KE; Bertler A
    Acta Pharm Suec; 1974 Nov; 11(5):459-70. PubMed ID: 4440504
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of digoxin absorption by neomycin.
    Lindenbaum J; Maulitz RM; Butler VP
    Gastroenterology; 1976 Sep; 71(3):399-404. PubMed ID: 950089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radioimmunochemical analysis of digoxin and digoxin derivatives in the serum and urine during normal and impaired kidney function].
    Larbig D; Haasis R; Bundschu HD; Buckesfeld RG; Lankisch PG; Ilg R; Girndt J
    Verh Dtsch Ges Inn Med; 1974; 80():1077-80. PubMed ID: 4454338
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of some organic solvents on the absorption of digoxin by man.
    Fowle AS; French J; O'Grady J
    Arzneimittelforschung; 1981; 31(6):1029-31. PubMed ID: 7196235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.